PDGFC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.052200E-01
Normal-vs-Stage2
8.188800E-01
Normal-vs-Stage3
5.047600E-01
Normal-vs-Stage4
6.756000E-01
Stage1-vs-Stage2
2.841400E-01
Stage1-vs-Stage3
8.916200E-01
Stage1-vs-Stage4
9.793900E-02
Stage2-vs-Stage3
3.303000E-01
Stage2-vs-Stage4
2.254200E-01
Stage3-vs-Stage4
1.790160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.102800E-01
Normal-vs-AfricanAmerican
7.561000E-01
Normal-vs-Asian
5.974600E-01
Caucasian-vs-AfricanAmerican
9.725800E-01
Caucasian-vs-Asian
6.701200E-01
AfricanAmerican-vs-Asian
7.716800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.864000E-01
Normal-vs-Female
8.551800E-01
Male-vs-Female
3.648600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.310800E-01
Normal-vs-Age(41-60Yrs)
9.968600E-01
Normal-vs-Age(61-80Yrs)
6.735000E-01
Normal-vs-Age(81-100Yrs)
6.154800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.284800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.804800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.921000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.179420E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.182800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.242600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.819800E-01
Normal-vs-Daily Drinker
4.098800E-01
Normal-vs-Weekly Drinker
8.176400E-01
Normal-vs-Occasional Drinker
9.776200E-01
Normal-vs-Social Drinker
9.317400E-01
Non Drinker-vs-Daily Drinker
8.276400E-01
Non Drinker-vs-Weekly Drinker
2.245200E-01
Non Drinker-vs-Occasional Drinker
3.010200E-01
Non Drinker-vs-Social Drinker
2.107200E-01
Daily Drinker-vs-Weekly Drinker
2.250000E-01
Daily Drinker-vs-Occasional Drinker
2.699200E-01
Daily Drinker-vs-Social Drinker
1.884440E-01
Weekly Drinker-vs-Occasional Drinker
7.212800E-01
Weekly Drinker-vs-Social Drinker
6.147800E-01
Occasional Drinker-vs-Social Drinker
9.317600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.606400E-01
Normal-vs-Grade 2
5.282300E-02
Normal-vs-Grade 3
1.965610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.195900E-04
Grade 1-vs-Grade 3
2.516100E-03
Grade 1-vs-Grade 4
4.606400E-01
Grade 2-vs-Grade 3
3.072800E-01
Grade 2-vs-Grade 4
5.282300E-02
Grade 3-vs-Grade 4
1.965610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.298600E-01
Normal-vs-NonDiabetic
7.312800E-01
Diabetic-vs-NonDiabetic
8.804600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.997000E-01
Normal-vs-NoPancreatitis
7.710000E-01
Pancreatitis-vs-NoPancreatitis
6.619400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.733200E-01
Normal-vs-N1
8.448600E-01
N0-vs-N1
2.758600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.605400E-01
Normal-vs-TP53-NonMutant
2.874400E-01
TP53-Mutant-vs-TP53-NonMutant
2.263400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
